![]() Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. | ![]() Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | |
Employees | Employees 233% decrease | Employees 5,8004% increase |
Valuation ($) | Valuation ($) 4.3 m | Valuation ($) 21.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) $1.9b (FY, 2025) |
Net income | Net income ($70.7m) (FY, 2022) | Net income ($2.8b) (FY, 2025) |
Operating ⚠ | ||
Patent Applications | Patent Applications 17 (FY, 2017) | Patent Applications 430 (FY, 2021) |
Patents (Foreign) | Patents (Foreign) 42 (FY, 2017) | Patents (Foreign) 110 (FY, 2021) |
Patents (US) | Patents (US) 18 (FY, 2017) | Patents (US) 170 (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 131.7m | Total funding raised $ 1.8b |

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company